Online Program

Alzheimer's disease and the visual system

Tuesday, November 5, 2013 : 5:10 p.m. - 5:30 p.m.

Denise Valenti, OD, Aging/VIsion Rehabilitation, MCPHS University School of Optometry, Quincy, MA
Ten million baby boomers in the United States will get Alzheimer's disease. Public health professionals can benefit from understanding the impact this neurodegenerative disease has on the visual system. This would result in more effective management of the condition and in more effective communication between providers within the neurodegenerative disease multidisciplinary team. Biomarkers through the visual system; nerve fiber deficits, lens opacities, retinal findings related to amyloid, as well as functional losses in eye movement, pupil response, contrast sensitivity and motion cognitive processing of visual information are important in disease diagnosis and management. Contributions from clinicians, rehabilitation specialists and public health providers with clinical expertise in vision can contribute to a higher quality of life for those with Alzheimer's disease and their families. Attendees will be able to identify biomarkers in the visual system that are part of the Alzheimer's disease process.

Introduction and demographics I. Alzheimer's Disease A. Brain pathology B. Retina 1. Amyloid deposit 2. Macula a. APOE genetics 3. RGC 4. Imaging a. Direct b. Optical Coherence Tomography c. Enhanced Imaging Research C. Lens 1. Amyloid deposit 2. Acetyl Choline Esterase Inhibitors D. Functional deficits 1. Contrast 2. Motion 3. Temporal processing 4. Pupil response

Learning Areas:

Chronic disease management and prevention
Clinical medicine applied in public health
Provision of health care to the public
Public health or related nursing
Social and behavioral sciences

Learning Objectives:
Identify: Attendees will be able to identify the biomarkers of Alzheimer's disease that develop in the visual system.

Keyword(s): Aging, Vision Care

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have expertise in the field of aging, cognition and the visual system.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.